NanOlogy

Nanology email format

Verified email-pattern data for Nanology is currently limited. You can still use the company insights and contact sections below.
Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or coating agents. LSAMs have a disproportionately large surface area to particle size ratio that enables retention of particles at the disease site and continuous local drug release over time with gradual systemic clearance at subtoxic levels. Initial investigational drugs are LSAM-PTX and LSAM-DTX, which have completed clinical trials in multiple solid tumors with excellent tolerability and promising signs of tumor response and immunomodulation. NanOlogy has established feasibility of forming LSAMs in multiple drug classes including taxanes, cisplatin, TKIs, and PARPIs. Therapeutic Potential: Therapeutic potential exists across the cancer disease spectrum with NanOlogy intratumoral investigational drugs. In local disease, the potential to delay or prevention of solid tumor progression as an alternative to organ removal or other invasive procedures as the only curative options. In metastatic disease, the potential for immunomodulation by sustained primary tumor cell death to boost the local and systemic response to immunoncology therapies without adding systemic toxicity.

Company Details

Employees
10
Founded
-
Address
3909 Hulen Street, Fort Worth,tx 76107,united States
Industry
Biotechnology Research
Website
nanology.us
Keywords
Oncology drug development and Intratumoral therapy.
HQ
Fort Worth, TX
Competitors
DPT Laboratories, ReST THERAPEUTICS, AQEMIA, BioSeeker Group, Optum, DFB Pharmaceuticals LLC, Prime Cell Therapy, NAYA Therapeutics, RateTalk, Learn It Together.
Looking for a particular NanOlogy employee's phone or email?

Nanology Questions

Explore related pages

NanOlogy company profile NanOlogy management contacts

Related company profiles:

Companies like NanOlogy

AQEMIA logo - Similar company to NanOlogy

Aqemia

78
NAYA Therapeutics logo - Similar company to NanOlogy

Naya Therapeutics

10
RateTalk logo - Similar company to NanOlogy

Ratetalk

NA
Learn It Together logo - Similar company to NanOlogy

Learn It Together

3
Prime Cell Therapy logo - Similar company to NanOlogy

Prime Cell Therapy

13
Optum logo - Similar company to NanOlogy

Optum

97.83K
BioSeeker Group logo - Similar company to NanOlogy

Bioseeker Group

5
DPT Laboratories logo - Similar company to NanOlogy

Dpt Laboratories

480
ReST THERAPEUTICS logo - Similar company to NanOlogy

Rest Therapeutics

10
DFB Pharmaceuticals LLC logo - Similar company to NanOlogy

Dfb Pharmaceuticals Llc

10

Top NanOlogy Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant